Identification
- Composition (DCI)
- irbesartanhydrochlorothiazide
- Manufacturer
- SUN PHARMACEUTICALS NORTH AFRICA S.A
- ATC code
- C09DA04
- Presentation
- Boite de 28
- Schedule / Reimb.
- A
- Hospital price
- 96.00 MAD
Indications
Traitement de l’hypertension artérielle essentielle. Cette association à dose fixe est indiquée chez les patients adultes dont la pression artérielle est insuffisamment contrôlée par l’irbésartan seul ou l’hydrochlorothiazide seul.
Find an open pharmacy
On-call pharmacies near you
About CO-IRBESAR SUN 300 MG / 25 MG
CO-IRBESAR SUN 300 MG / 25 MG is marketed in Morocco by SUN PHARMACEUTICALS NORTH AFRICA S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of CO-IRBESAR SUN 300 MG / 25 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about CO-IRBESAR SUN 300 MG / 25 MG
Answers to common questions from Moroccan patients about this drug.